FilingFirehose · free AI preview
ENDRA Life Sciences Inc.
NDRA · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Delisting
ENDRA Life Sciences Inc. (NDRA) filed a delisting notice on April 21, 2026, marking a material corporate event requiring immediate context and historical analysis. Our 90-day ingestion window detected no cyber incidents, but the delisting flag signals potential regulatory, compliance, or financial stress that demands deeper investigation. The full $49 Report adds 12-month filing history, dilution risk scoring, detailed 8-K context around the delisting trigger, financing runway analysis, and AI-detected anomalies in officer activity and disclosure patterns. This report turns a single red flag into actionable due diligence.
Want the full 5-section $49 Report on NDRA?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.